Year: 2011
Type: book-chapter
Abstract: In the last few years, it has become evident that the immunological component is of central\nimportance in Parkinson’s Disease (PD) pathogenesis and progression. This can also\ncertainly be said about the prominent role that the protein -synuclein (Syn) is currently\nbelieved to play in the pathobiology of this neurodegenerative disorder. Moreover, the\nmultiple mechanisms through which Syn might be affecting the immune system appear\nnot to be just a consequence of disease progression, but to actively contribute to the delicate\nbalance between neuroprotection and neurotoxicity that ultimately underlies a given stage\nof disease.\nPD is a proteinopathy, whose pathological hallmark is the presence of deposits of\naggregated Syn in intracellular fibrillar inclusions in neurons of the substantia nigra pars\ncompacta (SN) of the brain, known as Lewy bodies (LB) (Croisier et al., 2005; Spillantini et al.,\n1998), and the loss of dopaminergic neurons (Braak et al., 2003). Three missense mutations,\nA53T, A30P and E46K, as well as multiple copies of the wild-type (Wt) Syn gene, are\nlinked to early-onset, familial PD (Gasser, 2005; Kruger et al., 1998; Polymeropoulos et al.,\n1997; Zarranz et al., 2004). Given that Syn is the major component of LB in both familial\nand sporadic PD cases (Spillantini et al., 1998), Syn is considered a critical factor in PD\naetiology. Currently, the cellular and molecular mechanisms underlying the pathological\nactions of Syn are poorly understood, and the factors contributing to sporadic PD,\nrepresenting the vast majority of PD cases, are not known.
Source: InTech eBooks
Parent work: Towards New Therapies for Parkinson's Disease
DOI: 10.5772/17417
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W1600451809
